208. Jeffrey Kaditz, Founder & CEO of Q Bio

Today, I’m joined by Jeffrey Kaditz, founder & CEO of Q Bio,
a company democratizing personalized preventive health with
streamlined whole-body MRI’s and digital twin technology.


An engineer and serial entrepreneur, Jeffrey’s tackled everything
from fintech to mobile gaming. Now, he’s revolutionizing
healthcare at Q Bio, building a platform that promises to help
doctors detect disease and diagnose root causes early.


In this episode, we discuss the company’s clinical digital twin
technology. Plus, Jeffrey shares his vision for making the Star
Trek Medbay a reality and talks us through an automated physical
exam of the future.


In this episode, you’ll learn:


• Why Q Bio is more than an elective whole-body MRI company
• What Jeffrey sees as the biggest bottleneck in preventive
healthcare
• How the company’s machine-learning technology predicts health
over time


Subscribe to the podcast insider.fitt.co/podcast
Subscribe to our newsletter insider.fitt.co/subscribe
Follow us on LinkedIn linkedin.com/company/fittinsider


Q Bio’s Website: https://www.q.bio/


-


The Fitt Insider podcast is brought to you by Jack Taylor, our
exclusive PR partner. More than just PR, they’re creative
storytellers and brand builders who actually understand the
health and wellness industry. Learn more and get in touch at
https://fitt.co/jacktaylor


Chapters:


(00:00) Introduction 
(01:09) Q Bio and its mission
(03:53) Gathering and measuring human body data in a cost
efficient manner
(06:24) The possibility of fully automated physical exams in the
near future
(08:01) Challenges with interpreting and utilizing large amounts
of health data
(09:34) Developing a software platform to integrate health
information
(11:23)    MRI scans are not currently financially
feasible for the average person
(13:54) Building a solution to replace MRI’s
(15:42) The challenges of current whole body MRI technology
(18:00) What the Q scan looks like today, and what it will look
like in the future
(19:44) Biochemical analysis is the bottleneck of cost and quick
results
(22:58) Q Bio’s business model
(24:43) Quantifying change in the human body
(26:16) D2C or partner with healthcare
facilities/companies?
(28:57) Creating a solution that is more scalable and affordable
than MRI’s
(30:02) Estimated cost of a Gemini scan today
(30:51) Estimated timeline for when Q Bio will be accessible to
everyone
(32:50) Future vision and current science bottlenecks of the
Gemini scan
(34:07) Is automated personalized preventive health a
possibility?
(37:03) Other problems that if solved would dramatically improve
healthcare
(37:49) What’s on the horizon for Q Bio and where to follow
along
(38:48) Conclusion